Evidence map›Paper›PMID 42626385›Full record

ArticleACS applied nano materials2026

Rationally Designed Zwitterionic Peptides Improve siRNA Delivery of Cationic Diblock Copolymer-Based Nanoparticle Drug-Delivery Systems.

Clyde Overby, Baixue Xiao, Tiana Salomon, Jorge Jimenez, Nathanial Silvia, Danielle S W Benoit

Abstract read
In one paragraph

Article in ACS applied nano materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Clyde OverbyDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.
Baixue XiaoDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.
Tiana SalomonDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.
Jorge JimenezDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.
Nathanial SilviaDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.
Danielle S W BenoitDepartment of Biomedical Engineering University of Rochester, Rochester, NY, USA.

Funding

Tissue Engineering Strategies to Revitalize Bone AllograftsR01AR064200 · NIAMS · UNIVERSITY OF ROCHESTER · PI Danielle S. Benoit · 2013 to 2026
$4.0M
Engineering scarless repair of flexor tendon injuriesR01AR056696 · NIAMS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, BENOIT, DANIELLE S. · 2009 to 2019
$3.6M
Evaluation of a Novel Anti-Caries Approach to Modulate Virulence of S. mutansR01DE018023 · NIDCR · UNIVERSITY OF ROCHESTER · PI KOO, HYUN · 2008 to 2019
$3.4M
Engineered salivary gland tissue chips (Administrative Supplement)UH3DE027695 · NIDCR · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., DELOUISE, LISA A · 2019 to 2021
$3.0M
Engineered salivary gland tissue chipsUG3DE027695 · NIDCR · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., DELOUISE, LISA A · 2017 to 2018
$1.5M
Development of Anti-Fouling Peptide-Nanoparticle Conjugates for the Delivery of siRNA to FracturesF31AR076874 · NIAMS · UNIVERSITY OF ROCHESTER · PI OVERBY, CLYDE THOMAS · 2020 to 2022
$138k
NIAMS NIH HHS F31 AR076874NIAMS NIH HHS R01 AR056696NIAMS NIH HHS R01 AR064200NIDCR NIH HHS R01 DE018023NIDCR NIH HHS UG3 DE027695NIDCR NIH HHS UH3 DE027695
6 · The paper itself

Abstract

Nanoparticle drug delivery systems (NP DDS) have proven to be tremendously impactful for delivering therapeutic agents in cancer treatments, vaccinations, gene therapy, diagnostics, and enabled new agents such as RNA therapeutics. However, the exposure of NP DDS to biological milieus leads to the rapid adsorption of proteins and other molecules, forming a proteinaceous corona that obscures NP surface characteristics and controls the biological interactions of the NP DDS. This corona often potentiates phagocytic uptake, hindering the efficacy of targeting groups, and reducing NP drug delivery efficacy. Surface modifications to reduce protein adsorption can overcome these deleterious effects. Still, the repertoire of modifications is limited to poly(ethylene glycol) (PEG)and synthetic zwitterionic polymers. However, these anti-fouling strategies lack tunability, have off-target immunological effects, and suffer from targeting-limited steric hindrance, altogether motivating the development of alternative approaches. Peptides can uniquely form many zwitterions and have shown promise in reducing and controlling NP protein coronas as a function of peptide sequence. However, the impact of ZIPs on the drug delivery properties of polymeric NPs has not been explored. In this work, diverse zwitterionic peptides (ZIPs) predicted computationally to reduce protein adsorption by assessing peptide-peptide β-strand interaction energies were conjugated to pH-responsive cationic NPs. The resulting ZIP-NP conjugates exhibited up to 88% reduced protein adsorption versus unfunctionalized NP, resulting in a range of siRNA-mediated gene knockdown, outcomes that correlate with interaction energies. These data suggest that interaction energy is a promising design parameter for ZIPs. ZIP-NP also exhibited sequence-dependent variations in cellular uptake and circulation half-life, indicating ZIP-NPs are suitable for tuning and improving NP drug delivery characteristics.

Identifiers

PMID42626385
PMCPMC13492567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.